STK39 enhances the progression of Cholangiocarcinoma via PI3K/AKT pathway
Summary: Serine/threonine kinase 39 (STK39) is overexpressed in various tumor tissues and plays an essential role in tumor progression. In this study, we investigated the clinical value, as well as the potential functions and mechanisms of STK39 in cholangiocarcinoma (CCA). The results showed that S...
Guardado en:
Autores principales: | Xiaopei Hao, Yao Zhang, Yiwei Lu, Guoyong Han, Dawei Rong, Guoqiang Sun, Guangshun Sun, Weiwei Tang, Jindao Wu, Xuehao Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9dbaa665942a436bbb528e64f99d4966 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Targeting Immune Cells in the Tumor Microenvironment of HCC: New Opportunities and Challenges
por: Xiaopei Hao, et al.
Publicado: (2021) -
Tanshinone IIA affects the malignant growth of Cholangiocarcinoma cells by inhibiting the PI3K-Akt-mTOR pathway
por: Huayuan Liu, et al.
Publicado: (2021) -
Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma
por: Eun Jin Sun, et al.
Publicado: (2021) -
Aloin induced apoptosis by enhancing autophagic flux through the PI3K/AKT axis in osteosarcoma
por: Jiaming He, et al.
Publicado: (2021) -
Crosstalk between circRNAs and the PI3K/AKT signaling pathway in cancer progression
por: Chen Xue, et al.
Publicado: (2021)